Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-05-07
1998-03-03
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514539, 514524, 514567, 514605, 514620, 514648, 514650, 514652, 549445, 558422, 560 36, 560 42, 562441, 562451, 564 99, 564165, 564321, 564337, 564349, 564350, 564351, A61K 31135, A61K 31335, C07C21732, C07C21734
Patent
active
057234892
ABSTRACT:
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof wherein: R.sup.1 to R.sup.9 are as defined herein and m is the integer 0 or 1.
These compounds are beta 3 adrenergic receptor agonists and are useful, therefore for example, in the treatment of diabetes, obesity, gastrointestinal diseases and achalasia.
REFERENCES:
patent: 3562297 (1971-02-01), Howe et al.
patent: 3634511 (1972-01-01), Howe et al.
patent: 3655661 (1972-04-01), Wasson
patent: 3712927 (1973-01-01), Howe et al.
patent: 3812125 (1974-05-01), Wasson
patent: 3906110 (1975-09-01), Francis
patent: 3959486 (1976-05-01), LeCount et al.
patent: 4110472 (1978-08-01), Hiltmann et al.
patent: 4134983 (1979-01-01), Baldwin
patent: 4210753 (1980-07-01), Tominaga et al.
patent: 4289883 (1981-09-01), Tominaga et al.
patent: 4302588 (1981-11-01), Tominaga et al.
patent: 4338330 (1982-07-01), Gillet et al.
patent: 4338333 (1982-07-01), Ainsworth et al.
patent: 4374840 (1983-02-01), Shiratsuchi et al.
patent: 4479949 (1984-10-01), Iwao et al.
patent: 4482562 (1984-11-01), Shiratsuchi et al.
patent: 4552969 (1985-11-01), Iwao et al.
patent: 4558125 (1985-12-01), Iwao et al.
patent: 4707497 (1987-11-01), Cecchi et al.
patent: 4772631 (1988-09-01), Holloway et al.
patent: 4853383 (1989-08-01), Baldwin et al.
patent: 4990668 (1991-02-01), Mai et al.
patent: 5053514 (1991-10-01), Fujioka et al.
patent: 5061727 (1991-10-01), Bloom et al.
patent: 5198448 (1993-03-01), Fujioka et al.
patent: 5254595 (1993-10-01), Guzzi et al.
Petrov et al., Chemical Abstracts, Vo. 82, abstract 17546.
Poss Kathleen M.
Sher Philip M.
Washburn William N.
Bristol--Myers Squibb Company
Raymond Richard L.
Rodney Burton
LandOfFree
Aryloxypropanolamine beta 3 adrenergic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryloxypropanolamine beta 3 adrenergic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryloxypropanolamine beta 3 adrenergic agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2248003